Wenliang Tan
发表
Yu Chen,
Yuanyuan Du,
Cheng Sun,
2021,
International journal of general medicine.
Wenxin Li,
Wenliang Tan,
Huilong Li,
2022,
Cell Death & Disease.
Chunxian Huang,
Zhongqiu Lin,
Jing Li,
2018,
Gynecologic oncology.
Chuanzhao Zhang,
Yajin Chen,
H. Zhuang,
2022,
Frontiers in Oncology.
Yajin Chen,
Wenliang Tan,
Ze-jian Huang,
2017,
Surgical Endoscopy.
Lei Zhang,
Yajin Chen,
Jun Cao,
2017,
Oncology research.
Wenxin Li,
Yajin Chen,
Wenliang Tan,
2019,
Journal of Cancer.
Xiang Wu,
Wenliang Tan,
Ze-jian Huang,
2017,
Oncology research.
TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma
Yajin Chen,
Xuan Luo,
Jun Cao,
2018,
EBioMedicine.
Ziyu Zhang,
Yajin Chen,
H. Zhuang,
2022,
Journal of hepatocellular carcinoma.
Wenliang Tan,
Xinming Chen,
Changzhen Shang,
2022,
Journal of advanced research.
Yajin Chen,
H. Zhuang,
Wenliang Tan,
2023,
Journal of hepatocellular carcinoma.
Yajin Chen,
Wenliang Tan,
Changzhen Shang,
2022,
Frontiers in Molecular Biosciences.
Zhirong Lin,
Yajin Chen,
Wenliang Tan,
2019,
Cancer medicine.
Dezhi Hong,
P. Gu,
Wenliang Tan,
2021,
Clinical and experimental hypertension.
Zhijuan Xie,
Ya-jin Chen,
Wenxin Li,
2022,
Frontiers in Nutrition.
Ya-jin Chen,
Hong-xia Li,
Wenxin Li,
2021,
Frontiers in Medicine.
Bo Chen,
H. Zhuang,
Wenliang Tan,
2023,
Journal of Big Data.
Yajin Chen,
Wenliang Tan,
Jun Min,
2019,
HPB : the official journal of the International Hepato Pancreato Biliary Association.
miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1
Zhirong Lin,
Wenxin Li,
Ying Wei,
2020,
Annals of Translational Medicine.
Yong Yang,
Lan Hong,
H. Zeng,
2022,
International heart journal.
Wenxin Li,
Yajin Chen,
Wenliang Tan,
2018,
Cancer management and research.
Wenxin Li,
Yajin Chen,
Wenliang Tan,
2018,
Cancer management and research.
Hong-Xia Li,
Wenliang Tan,
Chenwei Tang,
2023,
European journal of internal medicine.
Wenliang Tan,
Chenwei Tang,
Zhiqin Xie,
2024,
Cell death & disease.